| The role of FIS in trans activation of stable RNA operons of E. coli. L Nilsson, A Vanet, E Vijgenboom, L Bosch The EMBO Journal 9 (3), 727-734, 1990 | 220 | 1990 |
| FOXL2: a central transcription factor of the ovary A Georges, A Auguste, L Bessiere, A Vanet, AL Todeschini, RA Veitia Journal of molecular endocrinology 52 (1), R17-R33, 2014 | 182 | 2014 |
| Evidence for Specific Secretion Rather than Autolysis in the Release of Some Helicobacter pyloriProteins A Vanet, A Labigne Infection and immunity 66 (3), 1023-1027, 1998 | 173 | 1998 |
| FIS-dependent trans activation of stable RNA operons of Escherichia coli under various growth conditions L Nilsson, H Verbeek, E Vijgenboom, C van Drunen, A Vanet, L Bosch Journal of bacteriology 174 (3), 921-929, 1992 | 160 | 1992 |
| CD4 T cells with effector memory phenotype and function develop in the sterile environment of the fetus X Zhang, B Mozeleski, S Lemoine, E Dériaud, A Lim, D Zhivaki, E Azria, ... Science translational medicine 6 (238), 238ra72-238ra72, 2014 | 137 | 2014 |
| Inferring regulatory elements from a whole genome. An analysis of Helicobacter pyloriσ80 family of promoter signals A Vanet, L Marsan, A Labigne, MF Sagot Journal of molecular biology 297 (2), 335-353, 2000 | 134 | 2000 |
| Promoter sequences and algorithmical methods for identifying them A Vanet, L Marsan, MF Sagot Research in Microbiology 150 (9-10), 779-799, 1999 | 110 | 1999 |
| Modulatory effects of unsaturated fatty acids on the binding of glucocorticoids to rat liver glucocorticoid receptors G Vallette, A Vanet, C Sumida, EA NUNEZ Endocrinology 129 (3), 1363-1369, 1991 | 79 | 1991 |
| Ribosomal protein methylation in Escherichia coli: the gene prmA, encoding the ribosomal protein L11 methyltransferase, is dispensable A Vanet, JA Plumbridge, MF Guérin, JH Alix Molecular Microbiology 14 (5), 947-958, 1994 | 53 | 1994 |
| Azurocidin, a natural antibiotic from human neutrophils: expression, antimicrobial activity, and secretion RP Almeida, A Vanet, V Witko-Sarsat, M Melchior, D McCabe, JE Gabay Protein expression and purification 7 (4), 355-366, 1996 | 50 | 1996 |
| Cotranscription of two genes necessary for ribosomal protein L11 methylation (prmA) and pantothenate transport (panF) in Escherichia coli K-12 A Vanet, JA Plumbridge, JH Alix Journal of bacteriology 175 (22), 7178-7188, 1993 | 39 | 1993 |
| Plasticity of the human IgM repertoire in response to long‐term spaceflight JI Buchheim, S Ghislin, N Ouzren, E Albuisson, A Vanet, S Matzel, ... The FASEB Journal 34 (12), 16144-16162, 2020 | 24 | 2020 |
| Socioenvironmental stressors encountered during spaceflight partially affect the murine TCR‐β repertoire and increase its self‐reactivity C Fonte, S Kaminski, A Vanet, L Lanfumey, C Cohen-Salmon, S Ghislin, ... The FASEB Journal 33 (1), 896-908, 2019 | 19 | 2019 |
| Antitarget, anti-SARS-CoV-2 leads, drugs, and the drug discovery–genetics alliance perspective C Pozzi, A Vanet, V Francesconi, L Tagliazucchi, G Tassone, A Venturelli, ... Journal of Medicinal Chemistry 66 (6), 3664-3702, 2023 | 15 | 2023 |
| In silico design of new inhibitors against hemagglutinin of influenza A Perrier, M Eluard, M Petitjean, A Vanet The Journal of Physical Chemistry B 123 (3), 582-592, 2018 | 11 | 2018 |
| Co-lethality studied as an asset against viral drug escape: the HIV protease case S Brouillet, T Valere, E Ollivier, L Marsan, A Vanet Biology direct 5, 1-13, 2010 | 11 | 2010 |
| VIRAPOPS: a forward simulator dedicated to rapidly evolved viral populations M Petitjean, A Vanet Bioinformatics 30 (4), 578-580, 2014 | 9 | 2014 |
| A new strategy to reduce influenza escape: detecting therapeutic targets constituted of invariance groups J Lao, A Vanet Viruses 9 (3), 38, 2017 | 6 | 2017 |
| Synthetic lethals in hiv: Ways to avoid drug resistance: Running title: Preventing hiv resistance M Petitjean, A Badel, RA Veitia, A Vanet Biology direct 10, 1-13, 2015 | 4 | 2015 |
| VIRAPOPS2 supports the influenza virus reassortments M Petitjean, A Vanet Source Code for Biology and Medicine 9, 1-3, 2014 | 4 | 2014 |
